Rothschild Investment LLC’s BioCryst Pharmaceuticals BCRX Stock Holding History

Rothschild Investment LLC’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.91K	Sell	201 -1	-0.5%	-$8	﹤0.01%	2581
2025 Q4	$1.58K	Sell	202 -103	-34%	-$745	﹤0.01%	2487
2025 Q3	$2.31K	Sell	305 -80	-21%	-$666	﹤0.01%	2143
2025 Q2	$3.45K	Sell	385 -20	-5%	-$186	﹤0.01%	1695
2025 Q1	$3.04K	Buy	405 +155	+62%	+$1.25K	﹤0.01%	1667
2024 Q4	$1.88K	Buy	250 +65	+35%	+$493	﹤0.01%	1839
2024 Q3	$1.41K	Buy	185 +75	+68%	+$570	﹤0.01%	1923
2024 Q2	$680	Buy	110 +85	+340%	+$469	﹤0.01%	1854
2024 Q1	$127	Buy	+25	New	+$141	﹤0.01%	2051

Other funds holding BCRX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return